Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Sabin Vaccine Institute is a non-profit organization and product development partnership (PDP) dedicated to making vaccines accessible, effective, and affordable. The institute focuses on developing vaccines for neglected tropical diseases (NTDs) and emerging infectious diseases, including hookworm, schistosomiasis, and filoviruses like Ebola and Marburg. Sabin operates through a collaborative model, partnering with academic, governmental, and industrial organizations to advance candidates from preclinical research through clinical trials. Their mission emphasizes global health equity by targeting diseases that primarily affect impoverished populations. The organization also works on vaccine advocacy and education to improve immunization coverage globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sabin Vaccine Institute Product Development Partnership.